FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof. In formula (I), is a single or double bond; R1 is C1-6 alkyl optionally substituted with C1-6 alkoxy or one to two halogen groups; R2 is hydrogen, unsubstituted C1-6 alkyl or -ORA2, where RA2 is an unsubstituted C1-6 alkyl; R3a is hydrogen and R3b is hydrogen; each of R4a and R4b in each case independently represent hydrogen or halogen, provided that if between C5 and C6 is a simple bond, then hydrogen in position C5 and substituent R4a, each independently, is represented in an alpha or beta configuration, and R4b is absent; each of R5, R6 and R7 in each case independently represent hydrogen, halogen, -NO2, -CN, -C(=O)RGA, -C(=O)ORGA, -SRGA, -S(=O)RGA, -S(=O)2RGA, -S(=O)2ORGA or C1-6 alkyl, optionally substituted with halogen; RGA in each case independently represents unsubstituted C1-6 alkyl; and where at least one of R5, R6 and R7 independently represents halogen, -NO2, -CN, -C(=O)RGA, -C(=O)ORGA, -SRGA, -S(O)RGA, -S(=O)2RGA, -S(=O)2ORGA or C1-6 alkyl, optionally substituted with halogen, where RGA is an unsubstituted C1-2 alkyl. Invention also relates to pharmaceutical compositions and to individual compounds.
.
EFFECT: technical result: novel compounds of formula (I) having properties of a GABA modulator.
46 cl, 52 dwg, 5 tbl, 71 ex
Title | Year | Author | Number |
---|---|---|---|
19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2812930C2 |
19-NOR NEUROACTIVE STEROIDS AND METHODS OF USING THEM | 2014 |
|
RU2700264C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND USE THEREOF | 2015 |
|
RU2699359C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2014 |
|
RU2754534C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
OXYSTEROLS AND THEIR APPLICATION METHODS | 2017 |
|
RU2754130C2 |
Authors
Dates
2018-12-25—Published
2014-04-17—Filed